VNDA Stock Analysis: Buy, Sell, or Hold?
VNDA - Vanda Pharmaceuticals Inc.
$6.05
-0.07 (-1.14%)
▼
5d:
+2.54%
30d:
-4.95%
90d:
-12.45%
BUY
HIGH Confidence
Analysis Updated: Jul 1, 2026 12:00 AM ET
Earnings: Jul 30, 2026
27d
Get Alerted When VNDA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: VNDA shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: VNDA shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: VNDA is currently trading at $6.05, which is considered fair relative to its 30-day fair value range of $5.87 to $6.29.
Technical Outlook: Technically, VNDA is in a downtrend. The price is approaching resistance at $6.20. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: VNDA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $14.12 (+133.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, VNDA is in a downtrend. The price is approaching resistance at $6.20. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: VNDA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $14.12 (+133.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$5.87 -
$6.29
Company Quality Score
60/100
(BUY)
Options IV Signal
42th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
83.3%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Options fairly priced (IV 42th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 133.5% below Wall St target ($14.12)
Trading Range Analysis
30-Day Trading Range
$5.87 -
$6.29
Current vs Trading Range
FAIR
Expected Move (7 Days)
±$0.65
(10.7%)
Support & Resistance Levels
Support Level
$5.75
Resistance Level
$6.20
Current Trend
Downtrend
Technical data as of
Jul 1, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-7.86
Wall Street Target
$14.13
(+133.5%)
Revenue Growth (YoY)
3.4%
Earnings Growth (YoY)
-95.9%
Profit Margin
-110.0%
Share & Embed Analysis
Last updated: July 02, 2026 12:49 AM ET
Data refreshes hourly during market hours. Next update: 1:49 AM
Data refreshes hourly during market hours. Next update: 1:49 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VNDA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
5
Sells
Net
INSIDERS SELLING
Recent Transactions
Gunther Birznieks
SELL
42431 shares
2026-03-02
Joakim Wijkstrom
SELL
30800 shares
2026-03-02
Kevin Patrick Moran
SELL
42442 shares
2026-03-02
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$106 | 63 BUY |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$57 | 51 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$276 | 54 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$123 | 56 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
